We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Quietly Offers Warranty on NSCLC Drug Xalkori Should it Fail to Show Benefit
Pfizer Quietly Offers Warranty on NSCLC Drug Xalkori Should it Fail to Show Benefit
Pfizer has quietly launched what it’s calling the Pfizer Pledge, a pilot program that attaches an insurance-backed warranty to the performance of the company’s 10-year-old lung cancer drug Xalkori, promising money back.